Abstract: Disclosed is a curable composition including a silicone (A) of a specific structure and a composition containing Si—OH group and Si—H group, a silicone (B) of a specific structure and a composition containing Si—OH group and Si—CH?CH2 group, and a hydrosilylation catalyst of a catalytic quantity containing at least one metal compound selected from the group consisting of platinum compounds, palladium compounds, and rhodium compounds. In this curable composition, as kind of each silicone and the content of Si—OH group are adjusted, in curing the silicone, foaming in a cured product can be inhibited by inhibiting a dehydration condensation reaction between Si—OH groups, as compared with a hydrosilylation reaction which is a reaction of Si—CH?CH2 group and Si—H group. Furthermore, an excellent adhesion to a base body such as semiconductor substrate can be given when making a cured film.

Abstract: A composition containing a metal compound and a siloxane compound (A) represented by general formula (1): wherein X is represented by general formula X1 or X2: wherein the number of X1 is 1-8; the number of X2 is 0-7; the sum of the number of X1 and the number of X2 is 8; R1 to R4 represent a hydrogen atom, a C1-8 alkyl group, alkenyl group, alkynyl group, or a C6-8 aryl group, a hydrogen atom thereof optionally being substituted by a fluorine atom; R5 represents a C1-18 alkyl group, alkenyl group, alkynyl group or aryl group, a hydrogen atom thereof being optionally substituted by a fluorine atom, a carbon atom being optionally substituted by an oxygen atom or a nitrogen atom; R6 represents a hydrogen atom, a vinyl group or an allyl group; m and n represent an integer of 1-4; and 3?m+n.

Abstract: [SUMMARY] [PURPOSE] The invention provides a novel therapeutic agent or prophylactic agent for cognitive disorders. [SOLUTION MEANS] The invention provides an antibody that participates in antigen-antibody reaction specifically with tau protein that has been phosphorylated in the vicinity of Ser413 of SEQ ID NO: 1, and a therapeutic agent or prophylactic agent for cognitive disorders comprising as an active ingredient a peptide that has been phosphorylated in the vicinity of Ser413.

Abstract: An image forming apparatus includes a power supply unit supplied with power from outside and supplies the power to respective units of the apparatus, and a power control unit that controls the power supply unit and includes a power-supply-state storage unit that stores a power-supply-ON state or a power-supply-OFF state. The power supply unit is switchable between a first power supply mode to supply the power to all of the respective units of the apparatus, and a second power supply mode to supply the power to the power control unit. When the power supplied from outside is restarted after being shut off, the power control unit sets the power supply unit to the first power supply mode if the power-supply-state storage unit stores the power-supply-ON state, and sets the power supply unit to the second power supply mode if the power-supply-state storage unit stores the power-supply-OFF state.

Abstract: An electronic apparatus comprising: a main body including a reception unit and a processing unit; and a power supply device switches between an operation state for supplying power from an external power source to the main body and a standby state for supplying power from a secondary battery to the reception unit without supplying power from the power source to the main body. Charging of the battery with power from the power source is performed during the operation state and is terminated when a value indicating power level of the battery reaches a threshold value Vt satisfying (discharge lower limit VL+Vs)?Vt<charge upper limit VH, Vs denoting a decrease in power level occurring when power from the battery is supplied to the reception unit for an estimated maximum duration of the standby state within a time period having a unit time length.

Abstract: When a key input unit or a touch panel is pressed, a control unit identifies the commanded function. Then, the control unit causes a human-body communication unit to start processing for establishing human-body communication with a portable device worn by a user. On receiving user information from the portable device, the control unit makes reference to an authentication table and determines whether or not there is an entry for the received user information therein. Further, the control unit determines whether or not use of the identified function, out of the functions corresponding to the received user information, is allowed. The control unit performs display on the touch panel, according to the result of the determination.

Abstract: After a toner image is transferred from a photoreceptor to an intermediate transfer belt, a surface of the photoreceptor is destaticized by a static eraser including a plurality of light emitting elements arranged in an axial direction of the photoreceptor. A first density sensor and a second density sensor for detecting densities of toner applied to the intermediate transfer belt are provided at a position where a large quantity of light from the static eraser is applied to the photoreceptor surface and a position where a small quantity of light from the static eraser is applied to the photoreceptor surface. In a case where a density difference between the detected toner densities exceeds a predetermined threshold value, a destaticization controller carries out an additional destaticizing operation by the static eraser.

Abstract: A composition containing a metal compound and a siloxane compound (A) represented by general formula (1): wherein X is represented by general formula X1 or X2: wherein the number of X1 is 1-8; the number of X2 is 0-7; the sum of the number of X1 and the number of X2 is 8; R1 to R4 represent a hydrogen atom, a C1-8 alkyl group, alkenyl group, alkynyl group, or a C6-8 aryl group, a hydrogen atom thereof optionally being substituted by a fluorine atom; R5 represents a C1-18 alkyl group, alkenyl group, alkynyl group or aryl group, a hydrogen atom thereof being optionally substituted by a fluorine atom, a carbon atom being optionally substituted by an oxygen atom or a nitrogen atom; R6 represents a hydrogen atom, a vinyl group or an allyl group; m and n represent an integer of 1-4; and 3?m+n.

Abstract: An image forming apparatus includes a charging device for performing charging and discharging using a power storage device, and a plurality of loads each serving as a target of power supply from said charging device and being used in operation of the image forming apparatus. The image forming apparatus obtains information about an operation status of the image forming apparatus and sets priorities for being a target of power supply from the charging device for the plurality of loads, according to the obtained information. The image forming apparatus controls power supply operation of the charging device according to the information about the remaining capacity of the power storage device and the set priorities.

Abstract: An image forming apparatus includes control units that are booted up in parallel after reset, and further includes: a display unit displaying, in multiple stages, overall boot-up progress that is boot-up progress of the entire apparatus; a display control unit controlling the display unit to display the overall boot-up progress, wherein the display control unit includes: an estimation subunit making estimation of the overall boot-up progress based on period counted after the reset; and a reception subunit receiving boot-up progress of each control unit, and until receiving the boot-up progress of each control unit or the boot-up progress of the latest control unit in terms of boot-up completion, the display control unit performs control based on the estimation, and after receiving the boot-up progress of each control unit or the boot-up progress of the latest control unit, the display control unit performs control based on the received boot-up progress.

Abstract: A siloxane compound according to the present invention is represented by the general formula (1): where X are each independently either X1 or X2 with the proviso that at least one of X is X1; R1 to R8 are each independently a hydrogen atom, a C1-C8 alkyl, alkenyl or alkynyl group, a phenyl group or a pyridyl group; each of R1 to R5 may have a carbon atom replaced by an oxygen atom and may have an ether bond, a carbonyl group or an ester bond in its structure; m is an integer of 3 to 8; n is an integer of 0 to 9; p is 0 or 1; and Y are each independently a cross-linking group. This siloxane compound according to the present invention has higher heat resistance and flowability and easy formability at lower temperatures as compared to conventional silsesquioxanes.

Abstract: A siloxane compound according to the present invention is represented by the general formula (1). wherein X are each independently either X1 or X2 with the proviso that at least one of X is X2; R1 to R5 are each independently a hydrogen atom, a C1-C8 alkyl, alkenyl or alkynyl group, a phenyl group or a pyridyl group; each of R1 to R5 may have a carbon atom replaced by an oxygen atom and may have an ether bond, a carbonyl group or an ester bond in its structure; m and n are each independently an integer of 1 to 10; and Y are each independently a specific cross-linking group. The siloxane compound according to the present invention has flowability and easy formability at lower temperatures as compared to conventional silsesquioxanes.

Abstract: An image forming apparatus comprises: an operation part having a display area and operable to receive an input from a user; a first display part operable to display, in a part of the display area, (i) a first image to be visible only from a range of a first viewing angle and (ii) a second image to be visible only from a range of a second viewing angle that does not overlap with the range of the first viewing angle; an audio output part operable to output an audio explaining the first image; and a second display part operable, while the audio explaining the first image is being output, to display, in a remaining part of the display area, a notification indicating that the audio explaining the first image does not correspond to the second image, such that the notification is visible from the range of the second viewing angle.

Abstract: An electronic apparatus comprising: a main body including a reception unit and a processing unit; and a power supply device switches between an operation state for supplying power from an external power source to the main body and a standby state for supplying power from a secondary battery to the reception unit without supplying power from the power source to the main body. Charging of the battery with power from the power source is performed during the operation state and is terminated when a value indicating power level of the battery reaches a threshold value Vt satisfying (discharge lower limit VL+Vs)?Vt<charge upper limit VH, Vs denoting a decrease in power level occurring when power from the battery is supplied to the reception unit for an estimated maximum duration of the standby state within a time period having a unit time length.

Abstract: The present invention relates to a novel method of obtaining a factor involved in appetite control and/or body weight control, as well as genes obtained by said method, polypeptides encoded by said genes, or novel polypeptides obtained from the information on polypeptides encoded by said genes as a means for treating, controlling or diagnosing diseases associated with eating disorders and/or body weight control. Also the present invention relates to substances that inhibit the effects of said genes or said polypeptides as a means for treating, controlling or diagnosing diseases associated with appetite control and/or body weight control. By using thiazolidine diones having a PPAR ? agonist activity, genes and polypeptides involved in appetite regulation and/or body weight reduction can be obtained. NESFATIN or the like obtained by said method can be used as a means for treating, controlling or diagnosing diseases associated with eating disorders and/or body weight control.

Abstract: When a user selects not to insert advertisement data into scan data when transferring the scan data from an MFP to a Web server, the MFP converts the advertisement data into an HTML format to transfer to the Web server in association with the scan data. Accordingly, a PC accessing the Web server displays a Web page showing contents of the advertisement and information including an icon functioning as means for requesting download of the scan data. The scan data inserted with no advertisement data is downloaded to the PC by operating the icon.

Abstract: The Job executing device comprises a Job executing unit of executing a job concerning image data, an execution instruction-receiving unit of receiving an instruction for job execution sent to the Job executing unit by a user who is authenticated by an authentication unit, a memory unit of storing the notification destination corresponding to user identification information inputted for user authentication, and a notification unit of notifying the notification destination corresponding to the inputted user identification information of the instruction of job execution after receipt of the instruction for job execution by the execution instruction-receiving unit.

Abstract: An image forming apparatus comprises at least one printer that prints inputted image data on a plurality of types of print sheets, an expiration time attribute detector that detects from the image data, data representing an expiration time attribute, and a controller that judges based on the detection result drawn by the expiration time attribute detector, on which type of print sheets the image data should be printed, among the plurality of types of print sheets, then controls the image forming apparatus itself based on the judgment.

Abstract: An object of the present invention is to identify a Nesfatin-1 receptor, and to provide a method for screening or designing a Nesfatin-1-action regulating substance or a Nesfatin-1-like action substance using the Nesfatin-1 receptor. A method for screening a Nesfatin-1-like action substance comprising steps of making a test substance act on a receptor protein selected from the group consisting of GPR3, GPR6 and GPR12, and of identifying the Nesfatin-1-like action substance based on a change of Nesfatin-1 action.

Abstract: A Multi-Functional Peripheral (MFP) comprising: a registration adjuster for making a registration adjustment by adjusting an image forming position of each color; a detector for detecting an intensity of a vibration; a transmitter for transmitting the image data to another apparatus via a network; and a controller for (i) interrupting an image formation if the intensity of the vibration is judged to be larger than a first threshold, (ii) instructing the transmitter to transmit the image data of the interrupted image formation to the another apparatus if the intensity of the vibration is judged to be larger than a second threshold that is larger than the first threshold, and (iii) after the vibration has ceased, instructing the registration adjuster to make the registration adjustment and then restarting the interrupted image formation.